American multinational healthcare company and retailer
The 340B program, which lets hospitals buy discounted outpatient drugs for low-income patients, is facing a new CMS rule changing reimbursement formulas to reduce payments by about 40%. The move aims to lower patient costs but could shrink hospital revenues and affect services and jobs. The rule follows an executive order in 2025 and reflects ongoing political battles between hospitals and the pharmaceutical industry.
CNBC’s 2026 America’s Top States for Business quality-of-life rankings have drawn criticism from conservatives who say the methodology unfairly targets red states. Critics argue the list conflicts with population growth data and different state policy outcomes.
The White House has convened a meeting with AI leaders to review a proposed cybersecurity framework for advanced models, following OpenAI's recent agent hacks and calls for greater government access. Attendees include executives from Hugging Face, Anthropic, and others; Meta and Alphabet may participate. Markets show mixed responses as investors watch the policy discussion unfold.
Foundayo, the oral GLP-1 weight-loss pill by Eli Lilly, has been authorised by the MHRA for weight management and type 2 diabetes. It will be available privately; NHS adoption depends on NICE evaluation. Several UK outlets report on uptake, pricing, side effects and competing pills, including Wegovy and Wegovy HD.
CVS Health has raised its 2026 guidance, citing stronger profits from its insurance and retail pharmacy segments and a marked improvement in its Aetna unit. The company is expanding GLP-1 weight-loss access through MinuteClinic, while flagging higher medical costs and macro risks.
Major U.S. medical societies have published coordinated guidance for flu, COVID-19 and RSV vaccinations after the FDA approved updated COVID and flu shots. The American Medical Association and partner groups have compiled evidence and tailored recommendations for age and risk groups while the CDC advisory process remains delayed by political and legal disputes. Enhanced and mRNA flu options are available for older adults.
The U.S. Department of Justice and Walmart have reached a settlement over claims that Walmart pharmacies violated the Controlled Substances Act by failing to report red flags tied to opioid prescriptions. Walmart has not admitted liability. The settlement resolves claims from 2013 onward, with earlier related actions already settled in 2022. Walmart shares edged higher after the announcement.
Rhode Island Gov. Dan McKee is facing Helena Foulkes in a rematch for the Democratic nomination. The Washington Bridge reconstruction has become a central issue, with voters weighing safety, cost, and timely completion as campaign ads highlight differing records.